Associations between artificial sweetener intake from cereals, coffee, and tea and the risk of type 2 diabetes mellitus: A genetic correlation, mediation, and mendelian randomization analysis
PLOS ONE · 07.02.2024 · 19 (2) · e0287496
DOI: 10.1371/journal.pone.0287496 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 07.02.2024. Verfasst von Youqian Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sweetening Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Previous studies have emphasized the association between the intake of artificial sweeteners (AS) and type 2 diabetes mellitus (T2DM), but the causative relationship remains ambiguous.
Methods
This study employed univariate Mendelian randomization (MR) analysis to assess the causal link between AS intake from various sources and T2DM. Linkage disequilibrium score (LDSC) regression was used to evaluate the correlation between phenotypes. Multivariate and mediation MR were applied to investigate confounding factors and mediating effects. Data on AS intake from different sources (N = 64,949) were sourced from the UK Biobank, while T2DM data were derived from the DIAbetes Genetics Replication And Meta-analysis.The primary method adopted was inverse variance weighted (IVW), complemented by three validation techniques. Additionally, a series of sensitivity analyses were performed to evaluate pleiotropy and heterogeneity.
Results
LDSC analysis unveiled a significant genetic correlation between AS intake from different sources and T2DM (r g range: -0.006 to 0.15, all P < 0.05). After correction by the false discovery rate (FDR), the primary IVW method indicated that AS intake in coffee was a risk factor for T2DM (OR = 1.265, 95% CI: 1.035–1.545, P = 0.021, P FDR = 0.042). Further multivariable and mediation MR analyses pinpointed high density lipoprotein-cholesterol (HDL-C) as mediating a portion of this causal relationship. In reverse MR analysis, significant evidence suggested a positive correlation between T2DM and AS intake in coffee (β = 0.013, 95% CI: 0.004–0.022, P = 0.004, P FDR = 0.012), cereal (β = 0.007, 95% CI: 0.002–0.012, P = 0.004, P FDR = 0.012), and tea (β = 0.009, 95% CI: 0.001–0.017, P = 0.036, P FDR = 0.049). No other causal associations were identified ( P > 0.05, P FDR > 0.05).
Conclusion
The MR analysis has established a causal relationship between AS intake in coffee and T2DM. The mediation by HDL-C emphasizes potential metabolic pathways underpinning these relationships
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
- Department of Law, Yangtze University, Jingzhou, Hubei, China.
- Department of Medicine, Yangtze University, Jingzhou, Hubei, China.
ORCID-Profile: Lin Li
Zitieren
APA
Zhang, Y., Tang, Z., Shi, Y., & Li, L. (2024). Associations between artificial sweetener intake from cereals, coffee, and tea and the risk of type 2 diabetes mellitus: A genetic correlation, mediation, and mendelian randomization analysis. PLOS ONE, 19(2), e0287496. https://doi.org/10.1371/journal.pone.0287496
Vancouver
Zhang Y, Tang Z, Shi Y, Li L. Associations between artificial sweetener intake from cereals, coffee, and tea and the risk of type 2 diabetes mellitus: A genetic correlation, mediation, and mendelian randomization analysis. PLOS ONE. 2024;19(2):e0287496. doi:10.1371/journal.pone.0287496
BibTeX
@article{Zhang2024,
author = {Zhang, Youqian and Tang, Zitian and Shi, Yong and Li, Lin},
title = {Associations between artificial sweetener intake from cereals, coffee, and tea and the risk of type 2 diabetes mellitus: A genetic correlation, mediation, and mendelian randomization analysis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {2},
pages = {e0287496},
doi = {10.1371/journal.pone.0287496}
}
EUVIMED